Podiatrist · New York, NY
NPI
1164473971
Since 2006
Specialty
Podiatrist
Code 213E00000X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
55 E 124th St
New York, NY, 10035
Phone (212) 410-8000
Groups this clinician bills Medicare through
Medicare paid, 2023
$2,758
49 services
Medicare patients, 2023
37
Average age 70
Drug cost, 2024
$100K
1,653 prescriptions
Company payments, 2025
$865
From 8 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Sharon R Barlizo was code 99213 (office e&m - established), 17 times for 15 patients. In total Sharon R Barlizo billed 49 services in 10 codes, and Medicare paid $2,758.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 17 | 15 | $59.70 | $1,015 |
By year: 2022 $2,224 for 49 services; 2023 $2,758 for 49 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon R Barlizo prescribed most often to Medicare patients was Clotrimazole, with 491 prescriptions and refills. In total Sharon R Barlizo wrote 1,653 Medicare prescriptions that cost $100K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clotrimazole Generic | 491 | 492 | 129 | $12K |
| Diclofenac Sodium Er Diclofenac Sodium | 379 | 379 | 35 | $30K |
| Doxepin Hcl Generic | 369 | 369 | 31 | $40K |
| Ammonium Lactate Generic | 155 | 157 | 75 | $3,740 |
| Diclofenac Sodium Generic | 64 | 65 | 25 | $831 |
| Naproxen Sodium Generic | 38 | 38 | 16 | $4,975 |
| Fluocinonide Generic | 27 | 27 | Under 11 | $2,007 |
| Etodolac Generic | 21 | 21 | 19 | $2,840 |
| Meloxicam Generic | 13 | 13 | Under 11 | $33.34 |
| Gabapentin Generic | 13 | 35 | Under 11 | $114 |
Brand drugs: 14 claims; generic drugs: 1,639 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon R Barlizo $865 ($865 in general payments such as food, travel and fees) from 8 companies. The largest payer was Organogenesis Inc. with $226.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.